Creation of the AMES Group-UPC Chair in design and innovation in the field of new biomaterials

+
Download

Rector Torres (left) and Cèsar Molins, shaking hands.

+
Download

The UPC's rector, Francesc Torres (left) and Cèsar Molins, general director of the AMES Group, sign the agreement for the creation of the Chair.

+
Download

Francesc Torres and Cèsar Molins, accompanied by the director of the Chair, José María Manero, and researcher Maria Pau Ginebra, along with other institutional and academic representatives of the University, and managers of the business group.

The AMES Group-UPC Chair, which was created at the Diagonal-Besòs Campus in Barcelona, will work in the field of additive manufacturing of porous metallic biomaterials for use in traumatology.

Jun 20, 2018

The Universitat Politècnica de Catalunya (UPC) and the AMES Group have created the AMES Group-UPC Chair in Design and Innovation in New Biomaterials, which promotes education, research, transfer of results and scientific dissemination in the field of additive manufacturing of metallic biomaterials. The coordinator and director of the Chair is José María Manero, professor of the Department of Materials Science and Metallurgy, and the management team is made up of teaching staff from the Biomaterials, Biomechanics and Tissue Engineering Group (BBT), led by Professor Maria Pau Ginebra, together with management staff of the AMES Group.

The BBT has already collaborated with the company in the design of a new product line, coinciding with the creation of a new division within the group, AMES MEDICAL, dedicated to porous biomaterials. The new chair on the Diagonal-Besòs Campus (Building I) is a continuation of this collaboration. It will carry out research, select advisory bodies in the fields of pharmaceuticals and niche markets, and analyse new materials and their reactions. It also plans to develop and optimise treatments for biomaterials, and to provide advice on innovation processes. The Chair will organise scientific seminars and conferences in this field.

The BBT develops biomaterials for the regeneration and functional repair of tissues and organs. It studies and designs materials capable of modifying the biological response of the host tissue, giving rise in some cases to regeneration and neoformation of the degraded tissues and in others to perfect integration of the biomaterial and functional recovery. It carries out research in three main areas: biomaterials for bone regeneration, plasmas for biomedical applications, and advanced metallic biomaterials. As a result of its experience and activity, the BBT has patented several technologies.

The AMES Group is a Spanish manufacturer of sintered metallic components with an annual turnover of €150 million. Its headquarters are in Sant Feliu de Llobregat and it has factories in Spain, Hungary, the United States and China. It has a sales and technical support network for more than 600 clients in more than 50 countries. It has consolidated itself as one of the leading companies worldwide in this field, and is committed to technological innovation and quality. It has received many awards for its continued efforts in technology and quality during its 60-year history.